Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram
Pathology Outlines - HER2 (c-erbB2) breast
HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram
Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews
HER2 status in breast Cancer: What does it mean? - Moose and Doc
Hormone receptor (ER, PR, HER2/neu) status and proliferation index marker (Ki-67) in breast cancers: Their onco-pathological correlation, shortcomings and future trends Iqbal BM, Buch A - Med J DY Patil Univ
The landscape of d16HER2 splice variant expression across HER2-positive cancers | Scientific Reports
Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO
Table 2 | TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy | SpringerLink
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge - Cancer Treatment Reviews
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology
/diagnosis-and-testing-for-her2-positive-breast-cancer-4151804-53c6bdb1bb654ed69ce7f967626b7e4e.png "HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival")
HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival
HER2-positive breast cancer - The Lancet
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway: Molecular Therapy
Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer | PNAS
Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity | Journal of Nanobiotechnology | Full Text
Breast cancer: a new target? | Recherche animale
HER2/neu - Wikipedia
Updated UK Recommendations for HER2 assessment in breast cancer | Journal of Clinical Pathology
Biologicals to direct nanotherapeutics towards HER2-positive breast cancers - ScienceDirect
Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities | HTML
Anti Human HER2/neu Antibody, clone ICR55 | Bio-Rad
